Author
@BiopharmIQ BiopharmIQ
Institutional-grade biotech catalyst and hedge-fund 13F data feed
Publishes a high-volume biotech intelligence feed: clinical/
trader score
·
hit rate
·
mean α
·
signals 14d
191
Grade = how their written analysis reads (A best). Trader score = how their last-20 timestamped calls performed vs SPY.
Their picks, scored
Not yet in the scored-bets universe (fewer than 20 scoreable calls). Their last-14d mentions, direction-adjusted, have moved -2.7% since posting (mean over 60 mentions with price data).
Recent signals15receipts included
| date (PT) | ticker | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|---|
| 2026-08-28 | IBB | @BiopharmIQ | +0.25 | Biotech fell for the week but retains strong YTD gains with catalysts potentially driving another leg | — | tweet ↗ |
| 2026-08-28 | IBB | @BiopharmIQ | +0.10 | Reports weekly declines and strong year-to-date gains for three biotech funds | — | tweet ↗ |
| 2026-08-28 | BBC | @BiopharmIQ | +0.45 | Biotech fell for the week but retains strong YTD gains with catalysts potentially driving another leg | · | tweet ↗ |
| 2026-08-28 | XBI | @BiopharmIQ | +0.15 | Reports weekly declines and strong year-to-date gains for three biotech funds | — | tweet ↗ |
| 2026-08-28 | XBI | @BiopharmIQ | +0.25 | Biotech fell for the week but retains strong YTD gains with catalysts potentially driving another leg | — | tweet ↗ |
| 2026-08-28 | BBC | @BiopharmIQ | +0.20 | Reports weekly declines and strong year-to-date gains for three biotech funds | · | tweet ↗ |
| 2026-08-28 | ARWR | @BiopharmIQ | +0.00 | Explains CELU's 139% move and lists upcoming biotech regulatory catalysts | · | tweet ↗ |
| 2026-08-28 | RARE | @BiopharmIQ | +0.00 | Explains CELU's 139% move and lists upcoming biotech regulatory catalysts | · | tweet ↗ |
| 2026-08-28 | CELU | @BiopharmIQ | +0.45 | Explains CELU's 139% move and lists upcoming biotech regulatory catalysts | · | tweet ↗ |
| 2026-08-28 | PTGX | @BiopharmIQ | +0.00 | Explains CELU's 139% move and lists upcoming biotech regulatory catalysts | · | tweet ↗ |
| 2026-08-28 | SMMT | @BiopharmIQ | +0.40 | Summarizes major weekly biotech gainers and BTAI's bankruptcy-driven 75% decline | — | tweet ↗ |
| 2026-08-28 | SPRB | @BiopharmIQ | +0.40 | Summarizes major weekly biotech gainers and BTAI's bankruptcy-driven 75% decline | · | tweet ↗ |
| 2026-08-28 | BTAI | @BiopharmIQ | -0.80 | Summarizes major weekly biotech gainers and BTAI's bankruptcy-driven 75% decline | · | tweet ↗ |
| 2026-08-28 | CELU | @BiopharmIQ | +0.60 | Summarizes major weekly biotech gainers and BTAI's bankruptcy-driven 75% decline | · | tweet ↗ |
| 2026-08-28 | MESO | @BiopharmIQ | +0.40 | Summarizes major weekly biotech gainers and BTAI's bankruptcy-driven 75% decline | · | tweet ↗ |
Grade is our human read-worthiness rating; trader score is a rolling 20-bet hit-rate/alpha composite — different things, often disagreeing. “Since then” is direction-unaware in the table; the summary line above adjusts for which way they leaned.